[CLINICO-THERAPEUTIC AND EPIDEMIOLOGICAL CONSIDERATIONS ON 1153 CASES OF BRUCELLOSIS].
D000293:Adolescent; D000900:Anti-Bacterial Agents; D002006:Brucellosis; D002648:Child; D002701:Chloramphenicol; D002751:Chlortetracycline; D003707:Demeclocycline; D004813:Epidemiology; D006801:Humans; D016233:Immunotherapy, Active; D007223:Infant; D007558:Italy; D009827:Oleandomycin; D013223:Statistics as Topic; D013307:Streptomycin; D013752:Tetracycline
D000900:Anti-Bacterial Agents; D003707:Demeclocycline; D002701:Chloramphenicol; D013752:Tetracycline; D009827:Oleandomycin; D002751:Chlortetracycline; D013307:Streptomycin
ADOLESCENCE; BRUCELLOSIS; CHILD; CHLORAMPHENICOL; CHLORTETRACYCLINE; DEMETHYLCHLORTETRACYCLINE; EPIDEMIOLOGY; INFANT; ITALY; OLEANDOMYCIN; STATISTICS; STREPTOMYCIN; TETRACYCLINE; VACCINE THERAPY
CONSIDERAZIONI CLINICO-TERAPEUTICHE ED EPIDEMIOLOGICHE SU 1153 CASI DI BRUCELLOSI.